Ernest Moy, MD, MPH, is the Executive Director of the Office of Health Equity of the VHA. This office supports and coordinates efforts to understand and reduce disparities in health and health care affecting veterans. Prior to joining VHA, he was a Medical Officer in the Office of Analysis and Epidemiology at the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC). At CDC, he studied rural health disparities, analyzed linked hospital-vital statistics data to identify care patterns that placed patients at high risk for opioid poisoning death, and developed new data visualizations and partnerships for disseminating health statistics.
Juan Quinones focuses primarily on procurements for information technology products and services, and specializes in innovatively procuring digital services. He has experience supporting procurements for mobile application and platform development, and Application Programming Interface development. Prior to the TAC Juan was a Contract Specialist at the Army Communications-Electronics Life Cycle Management Command located at Fort Monmouth. Read more.
Mary Ann Slack serves as Director of CDER’s Office of Strategic Programs (OSP). OSP plays a lead role in many of the center’s strategic initiatives and modernization efforts, including development of benefit-risk and other decision support tools, data standardization, lean process management, program analysis, informatics, capacity planning, and major user fee negotiations. OSP leads implementation of CDER’s business informatics governance function in support of business modernization objectives.Since joining CDER in 2003, Ms. Slack has led numerous large, complex initiatives with broad stakeholder impact. She established and leads CDER’s data standards program, co-chairs FDA’s Data Standards Advisory Board, and represents FDA’s needs on HL7’s Board of Directors. She successfully led the cross-organizational Pharmaceutical Program Alignment implementation working group , leads a cross-organizational expert team in defining FDA’s capability assessments of inspectorates and operational implementation of the FDA-EU mutual recognition agreement, and represents FDA as a topic expert on ICH’s MedDRA Management Committee and M2 multidisciplinary working group.
Karen L. Brazell was appointed Principal Executive Director for the Office of Acquisition, Logistics and Construction (OALC) on August 6, 2018. As the advisor to the Deputy Secretary on acquisition, logistics, and construction issues she directs the development of policies, determines priorities, and establishes organizational goals and objectives for OALC. She also serves as Chief Acquisition Officer, overseeing acquisition, contract administration and supply-chain processes for the Department. Prior to joining the Department of Veterans Affairs, Mrs. Brazell served as Chief of Staff for the White House Military Office where she oversaw strategic planning, engagement planning, communication product development, staff coordination and integration, special projects, policy development, and resource management. Prior to that, she served as Deputy Director of the Acquisition and Resource Integration, Naval Facilities Command, responsible for enterprise-wide acquisition and resource integration for the White House Military Office, Policy, Plans and Requirements directorate. Mrs. Brazell is a United States Army Veteran.
Karen Jackson is Deputy Chief Operating Officer. In this capacity she provides executive leadership for all aspects of program operations support for a $6 billion annual budget, including information technology, human capital, security, contracting and acquisition, risk management and regional operations for an agency responsible for over 100 million beneficiaries in Medicare, Medicaid and the Children’s Health Insurance Program (CHIP). Karen most recently served as Deputy Director of the CMS Innovation Center, established in 2010 as part of the Affordable Care Act to test new health care payment and service delivery models that improve quality and lower costs, with $10 billion for the initial 10 year period.